BMS-202

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBMS-202
Drug Alias NameBMS-202PCC-0208025
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProgrammed cell death protein 1 blockersProgrammed death-ligand 1 blockers
TargetsProgrammed cell death protein 1Programmed death-ligand 1
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBinzhou Medical College
China Registration ClassN/A

Develop Information

Active CompaniesBinzhou Medical College
Inactive CompaniesN/A
Active IndicationsMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A